BioLargo financials at a glance
Year | Year | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2006 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rev. | Revenue |
|
$0.08M | $0.00M | $0.14M | $0.16M | $0.16M | $0.07M | $0.17M | $0.11M | $0.13M | $0.28M | $0.52M | $1.36M | $1.86M | $2.43M | $2.53M | $0.00M | $5.88M | $0.00M | $0.00M |
GM % | Gross Margin % |
|
100.00% | 0.00% | 17.07% | 19.95% | 71.34% | 39.30% | 82.34% | 49.80% | 51.35% | 62.34% | 37.40% | 45.53% | 49.22% | 50.49% | 43.58% | 0.00% | 48.56% | 0.00% | 0.00% |
OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -251.80% | 0.00% | -87.19% | 0.00% | 0.00% |
EPS | Earnings Per Share |
|
$-0.02 | $0.00 | |||||||||||||||||
Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sha. | Shares |
|
39.81m | 42.22m | 42.9m | 48.86m | 58.32m | 70.24m | 74.48m | 82.07m | 85.79m | 89.92m | 102.61m | 132.54m | 163.93m | 224.13m | 228.15m | 0m | 266.87m | 0m | 0m |
OCF | Operating Cash Flow |
|
$-1.29M | $-1.90M | $-1.37M | $-1.30M | $-1.72M | $-2.03M | $-1.21M | $-1.72M | $-1.88M | $-3.72M | $-4.28M | $-3.89M | $-4.42M | $-4.15M | $-3.94M | $-1.32M | $-2.76M | $0.00M | $0.00M |
FCF | Free Cash Flow |
|
$0.00M | $-1.93M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $-3.78M | $-4.31M | $-3.95M | $-4.46M | $-4.17M | $-3.96M | $0.00M | $-3.03M | $0.00M | $0.00M |
FCFS | Free Cash Flow Per Share |
|
$-0.04 | $-0.05 | $-0.03 | $-0.03 | $-0.03 | $-0.03 | $-0.02 | $-0.02 | $-0.02 | $-0.04 | $-0.04 | $-0.03 | $-0.03 | $-0.02 | $-0.02 | $-0.48 | $-0.01 | $0.00 | $0.00 |